Matthew D. Snape

24.4k total citations · 1 hit paper
128 papers, 3.7k citations indexed

About

Matthew D. Snape is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Matthew D. Snape has authored 128 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Epidemiology, 74 papers in Microbiology and 20 papers in Infectious Diseases. Recurrent topics in Matthew D. Snape's work include Pneumonia and Respiratory Infections (75 papers), Bacterial Infections and Vaccines (74 papers) and Influenza Virus Research Studies (46 papers). Matthew D. Snape is often cited by papers focused on Pneumonia and Respiratory Infections (75 papers), Bacterial Infections and Vaccines (74 papers) and Influenza Virus Research Studies (46 papers). Matthew D. Snape collaborates with scholars based in United Kingdom, United States and Belgium. Matthew D. Snape's co-authors include Andrew J. Pollard, Ly‐Mee Yu, Tessa M. John, Ray Borrow, Daniela Toneatto, Dominic F. Kelly, Peter Dull, Ellen Ypma, Charlotte Barker and Russell Viner and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

Matthew D. Snape

126 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

2022 115 citations Joanne Wildenbeest, Marie‐Noëlle Billard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew D. Snape United Kingdom	33	2.7k	2.0k	539	426	286	128	3.7k
Mark M. Blatter United States	32	3.1k 1.1×	925 0.5×	540 1.0×	489 1.1×	343 1.2×	84	4.2k
Markus Knuf Germany	34	3.0k 1.1×	1.3k 0.7×	759 1.4×	494 1.2×	382 1.3×	139	3.9k
Per Olcén Sweden	38	2.8k 1.0×	2.1k 1.1×	623 1.2×	230 0.5×	140 0.5×	144	4.0k
Nancy E. Messonnier United States	28	2.4k 0.9×	2.4k 1.2×	526 1.0×	122 0.3×	417 1.5×	46	3.3k
Terhi Kilpi Finland	37	4.6k 1.7×	2.7k 1.3×	543 1.0×	324 0.8×	251 0.9×	110	5.8k
Jon S. Abramson United States	26	1.6k 0.6×	676 0.3×	615 1.1×	374 0.9×	397 1.4×	66	2.8k
Colin D. Marchant United States	33	2.2k 0.8×	1.2k 0.6×	420 0.8×	189 0.4×	278 1.0×	78	3.4k
Elaine L. Mills Canada	34	1.4k 0.5×	817 0.4×	385 0.7×	573 1.3×	175 0.6×	76	2.8k
Pauline A. Waight United Kingdom	24	3.0k 1.1×	1.1k 0.5×	341 0.6×	213 0.5×	473 1.7×	32	3.5k
Jo Southern United Kingdom	30	1.9k 0.7×	1.1k 0.6×	1.4k 2.5×	334 0.8×	652 2.3×	89	3.4k

Countries citing papers authored by Matthew D. Snape

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Snape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Snape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Snape more than expected).

Fields of papers citing papers by Matthew D. Snape

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Snape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Snape. The network helps show where Matthew D. Snape may publish in the future.

Co-authorship network of co-authors of Matthew D. Snape

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Snape. A scholar is included among the top collaborators of Matthew D. Snape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Snape. Matthew D. Snape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ziegler, Anette‐Gabriele, Peter Achenbach, Andreas Weiß, et al.. (2025). Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial. The Lancet. 406(10519). 2564–2576.

Lin, Gu-Lung, Simon B. Drysdale, Matthew D. Snape, et al.. (2024). Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus. Nature Communications. 15(1). 2379–2379. 20 indexed citations

Weiß, Andreas, Thekla von dem Berge, Kristina Casteels, et al.. (2024). Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic. Infection. 52(6). 2465–2473. 2 indexed citations

Kazmin, Dmitri, Elizabeth Clutterbuck, Giorgio Napolitani, et al.. (2023). Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children. npj Vaccines. 8(1). 100–100. 9 indexed citations

Mao, Zhuxin, Xiao Li, Ana Dacosta-Urbieta, et al.. (2023). Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. Vaccine. 41(16). 2707–2715. 29 indexed citations

Winkler, Christiane, Rachel Besser, Angela Hommel, et al.. (2022). The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT ‐study. Pediatric Diabetes. 23(8). 1707–1716. 5 indexed citations

Hoang, Uy, Simon de Lusignan, Mark Joy, et al.. (2022). National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study. Archives of Disease in Childhood. 107(8). 733–739. 15 indexed citations

Ziegler, Anette‐Gabriele, Peter Achenbach, Reinhard Berner, et al.. (2021). Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol. BMJ Open. 11(11). e052449–e052449. 21 indexed citations

Wagstaffe, Helen R., Elizabeth Clutterbuck, Viki Bockstal, et al.. (2020). Ebola virus glycoprotein stimulates IL-18–dependent natural killer cell responses. Journal of Clinical Investigation. 130(7). 3936–3946. 15 indexed citations

10.

Carr, Jeremy, Emma Plested, Parvinder K. Aley, et al.. (2020). ‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents. BMJ Open. 10(10). e037358–e037358. 10 indexed citations

11.

Cicconi, Paola, Claire Jones, Laura Silva-Reyes, et al.. (2019). First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Clinical Infectious Diseases. 70(10). 2073–2081. 43 indexed citations

12.

Ziegler, Anette‐Gabriele, Peter Achenbach, Reinhard Berner, et al.. (2019). Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open. 9(6). e028578–e028578. 58 indexed citations

13.

Galal, Ushma, et al.. (2017). An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study. Archives of Disease in Childhood. 102(10). 958–962. 26 indexed citations

14.

Marshall, Helen, et al.. (2016). Control of invasive meningococcal disease. International Journal of Evidence-Based Healthcare. 14. 3–14. 1 indexed citations

15.

Pask, Sophie, et al.. (2016). Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals. Vaccine. 34(34). 4056–4061. 14 indexed citations

16.

Khatami, Ameneh, Matthew D. Snape, Clarissa Oeser, et al.. (2013). Phase II Study of a Three-dose Primary Vaccination Course of DTPa-IPV/Hib-MenC-TT Followed by a 12-month Hib-MenC-TT Booster in Healthy Infants. The Pediatric Infectious Disease Journal. 32(6). 675–681. 3 indexed citations

17.

Blanchard‐Rohner, Géraldine, Matthew D. Snape, Dominic F. Kelly, et al.. (2013). Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom. The Pediatric Infectious Disease Journal. 32(7). 768–776. 14 indexed citations

18.

Walker, Woolf, Matthew D. Snape, Clarissa Oeser, et al.. (2011). A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children. Health Technology Assessment. 15(45). v–vi, xi. 4 indexed citations

19.

Perrett, Kirsten P., Matthew D. Snape, Karen Ford, et al.. (2009). Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants. The Pediatric Infectious Disease Journal. 28(3). 186–193. 52 indexed citations

20.

Snape, Matthew D., Kirsten P. Perrett, Karen Ford, et al.. (2006). ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact